Related Experiment Video
Updated: May 22, 2026
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Renal cell carcinoma deep sequencing: recent developments
Leslie J Farber1, Kyle Furge, Bin Tean Teh
1ljfarber@gmail.com
Abstract:
Renal cell carcinoma (RCC) is the most common type of renal cancer in adults. RCC is notoriously resistant to current therapies suggesting the need to improve our knowledge and create more effective therapies. The molecular genetic defects that occur in RCC are extensive and complex ranging from single DNA changes, to large chromosomal defects, to signature disruptions in the transcription of hundreds of genes. These changes are often shared within each histological RCC subtype, illustrating their significance to the disease phenotype. This review presents an overview of the genetic abnormalities that occur within the most common subtypes of RCC. We discuss the recent molecular findings that have advanced our understanding of the somatic architecture of renal tumors and their impact on disease therapeutics.
Insights
Renal cell carcinoma (RCC) involves complex genetic defects. Understanding these molecular changes is key to developing more effective treatments for this common kidney cancer.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Renal cell carcinoma (RCC) is the predominant kidney cancer in adults.
- Current RCC therapies exhibit limited efficacy, highlighting a critical need for improved treatment strategies.
- The molecular pathogenesis of RCC is characterized by extensive and intricate genetic alterations.
Purpose of the Study:
- To provide a comprehensive overview of genetic abnormalities in common RCC subtypes.
- To elucidate the significance of molecular genetic defects in RCC phenotype.
- To discuss recent advancements in understanding renal tumor somatic architecture and therapeutic implications.
Main Methods:
- Review of current scientific literature on RCC genetics.
- Analysis of molecular genetic findings across various RCC subtypes.
- Synthesis of information on the impact of genetic alterations on therapeutic outcomes.
Main Results:
- RCC subtypes exhibit distinct patterns of genetic abnormalities, including DNA changes and chromosomal defects.
- Gene transcription disruptions are frequently observed and subtype-specific.
- Understanding somatic architecture provides insights into RCC biology.
Conclusions:
- Genetic abnormalities are fundamental to RCC development and classification.
- Advances in molecular genetics are crucial for improving RCC treatment strategies.
- Further research into the molecular landscape of RCC promises to enhance therapeutic development.
